<DOC>
	<DOCNO>NCT00574834</DOCNO>
	<brief_summary>The study focus determine integrate in-vivo mechanism responsible Ramipril 's effect delay type 2 diabetes restore normal ( blood sugar level ) glycemia patient impair glucose tolerance . Hypothesis - Ramipril effect delay onset type 2 diabetes restore normal glycemia patient impair glucose tolerance .</brief_summary>
	<brief_title>Mechanisms Ramipril Reduction Onset Type 2 Diabetes</brief_title>
	<detailed_description>Several study demonstrate therapeutic agent use reduce glucose level and/or weight delay onset type 2 diabetes . Intriguingly , angiotensin convert enzyme ( ACE ) inhibitor angiotensin receptor blocker ( ARB ) also result reduction onset type 2 DM . The striking effect find Ramipril HOPE study . The onset new type 2 DM reduce 34 % ( p &lt; 0.001 ) compare placebo . Furthermore , result DREAM trial demonstrate Ramipril dose 15 mg significantly reverse impaired glucose tolerance . However , mechanism underlie Ramipril effect delay type 2 diabetes know . The proposal focus determine integrate in-vivo mechanism responsible Ramipril 's effect delay type 2 DM restore normal glycemia patient impair glucose tolerance . The specific aim project : - determine effect Ramipril insulin resistance level liver peripheral tissue , - determine effect Ramipril endothelial function , - determine effect Ramipril insulin secretion , - determine effect Ramipril substrate flux , lipolysis inflammatory cytokine .</detailed_description>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Ramipril</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<criteria>Inclusion : 48 ( 24 male / 24 female ) impair glucose tolerance . Impaired blood glucose value outline American Diabetes Association guideline . Fasting plasma glucose 100 126 mg/dl 2 hour post prandial glucose 140 200 mg/dl BMI &gt; 25 kgM2 Age : 2065 year Treated Untreated hypertension define measurement seat BP screen visit systolic BP 120 150 and/ diastolic BP 80 100 . Exclusion : Patients receive agent increase low blood glucose , i.e. , metformin , thiazolidinediones , sulfonylurea , glitinides , acarbose , GLP1 receptor agonist Untreated treated seat Systolic Blood pressure &gt; 150and/or Diastolic Blood pressure &gt; 100 Taking hypertensive medication HCTZ ACE/ARB Allergy HCTZ , heparin , nitroglycerin lidocaine History allergy unacceptable side effect ACE inhibitor Pregnancy intent become pregnant study Smoking Subject unable give voluntary informed consent Physical Exam Exclusion Criteria Clinically significant Cardiac Abnormalities ( e.g . Heart Failure , Arrhythmia ) history ECG subject &gt; 40 year old Pneumonia Hepatic Failure/Jaundice Renal Failure Acute Cerebrovascular/ Neurological deficit Fever great 38.0 C Screening Laboratory Tests Exclusion Criteria accord protocol</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>